Evidence Summary: What the Data Suggest Several phase 2 and observational studies highlight the hepatic benefits of GLP1based treatment: Reduced liver fat: Repeated findings in imaging-based studies support this effect Lower liver enzymes: Consistent reductions in ALT/AST levels Fibrosis improvement: Promising trends in noninvasive markers, though further trials are needed While the strongest evidence comes from patients with obesity or type 2 diabetes, benefits in leaner, metabolically abnormal patients are increasingly documented, suggesting broader utility
I've seen this quite a bit in my Dallas-Fort Worth patients, especially folks who eat later dinners and then lie down a couple hours later
GLP BodyGuard is not appropriate as a substitute for medical care
A., Farrin, N., Mobasseri, M., Taghizadeh, A., & Ostadrahimi, A
Besides, geniposide suppressed A accumulation and alleviated cognitive dysfunction in APP/PS1 mice, attenuated A-induced reduction of LTP in acute hippocampal slices, and attenuated A-induced synaptic dysfunction in cultured hippocampal neurons (221, 222)
In our experience, approximately 15-20% of SAG samples submitted by new suppliers for qualification fail this initial odor screen